Role of miR-193a in Cancer: Complexity and Factors Control the Pattern of its Expression

Author(s): Afraa Mamoori, Vinod Gopalan, Alfred K-Y Lam*

Journal Name: Current Cancer Drug Targets

Volume 18 , Issue 7 , 2018

  Journal Home
Translate in Chinese
Become EABM
Become Reviewer
Call for Editor

Graphical Abstract:


Background: There is emerging data suggesting that the non-coding RNA (microRNA 193a or miR-193a) plays key roles in different types of cancers.

Objective: This review aims to investigate the functional significance of miR-193a in different cancers according to the information of literature.

Method: All the literature concerning miR-193a in cancer in PubMed are analysed.

Results: Several studies proved the association of miR-193a expression patterns with cancer’s stages, grades, response to the chemotherapy and even patient survival. Also, miR-193a can be used to differentiate some types of cancer. In cancer, miR-193a can act as a tumour suppressor gene or as an oncogene. Till now, several genetic factors (MAX, RXR α, XB130, P63, P73, AEG-1, HIFs, EGFR, Drosha, DGCR8, Dicer) and epigenetic factors (DNA methylation and long non-coding RNAs) were predicted to control miR-193a expression. They have fundamental effects on its biological behaviour in different types of cancers.

Conclusion: miR-193a has significant roles in cancer and can be targeted in the future for cancer therapy by better understanding of the factors that control its biological behaviour.

Keywords: miR-193a, cancer, chemotherapy, prognosis, mechanism, methylation.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2018
Page: [618 - 628]
Pages: 11
DOI: 10.2174/1568009618666180308105727
Price: $65

Article Metrics

PDF: 44
PRC: 1